Market Access

Resuscitating the Relationship between Medicines and Medicine

How can we overcome the current antagonism between prescribers and prescription drug makers and ...

Regulatory Compliance: The Importance of Training the Field Sales Force

The manner in which life sciences companies interact with healthcare practitioners and healthcare organizations ...

Phase 3C – Market Approval and the Soft Launch

For years we have followed the logical progression of products through clinical trials and ...

Strategic Priorities for Specialty Care Products

By 2013, specialty drugs will account for half of all pharmaceutical spending…and most of ...

Turning Competitive Intelligence Into a Winning Strategy

The emergence of social media, evolving prescriber information demands, and new data sources makes ...

The Paradigm Shift in Key-Opinion-Leader Marketing: A Brief

Expanded reporting requirements, especially the Sunshine Act, will accelerate the migration away from product-driven ...

Pricing for Indication Launch Sequence: Three Key Questions

What drives profits for a new pharmaceutical? Price. Optimizing the profits of a pharmaceutical ...

Payer Access Decisions in Hypoglycemics

While other drug categories have matured, hypoglycemics remain one of the fastest growing categories ...

Movers & Shakers

SKALA and GOLD AbelsonTaylor has hired Brittany Skala and Jennifer Gold as account supervisors. ...